TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.

Jonathan H Shepherd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.